IDIOPATHIC JUVENILE OSTEOPOROSIS - EVIDENCE OF NORMAL OSTEOBLAST FUNCTION BY 1,25-DIHYDROXYVITAMIN-D3 STIMULATION TEST

被引:13
作者
BERTELLONI, S
BARONCELLI, GI
DINERO, G
SAGGESE, G
机构
[1] Calcium Research Center, Endocrine Unit, Department of Pediatrics, University of Pisa, Pisa
关键词
IDIOPATHIC JUVENILE OSTEOPOROSIS; OSTEOBLAST FUNCTION; OSTEOCALCIN; 1,25(OH)2D3 ADMINISTRATION;
D O I
10.1007/BF00296211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Idiopathic juvenile osteoporosis (IJO) is a rare form of bone demineralization that occurs during childhood. The mechanism of bone loss is unclear. Some bone hystomorphometric studies have found osteoblast failure and decreased bone formation in the affected patients whereas others have reported increased bone resorption. To elucidate this issue, we studied osteoblast function in six patients with IJO (five males, one female; aged 2.3-14.6 years) and five healthy sex- and age-matched subjects (four males, one female; aged 2.0-15.1 years) measuring serum values of osteocalcin under basal condition and during an osteoblast stimulation test performed by oral 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] administration (1.8-mu-g/1.73 m2 /daily). After a baseline day (day 0), all the subjects (patients and controls) received 1,25(OH)2D3 in four divided doses for 6 days (days 1-6). Fasting blood samples were obtained every morning (0800 h) for the determination of serum osteocalcin. Baseline osteocalcin levels were not significantly different between IJO and controls (13.58 +/- 6.05 ng/ml versus 16.04 +/- 5.09 ng/ml, respectively) even if two patients had low osteocalcin values. During 1,25(OH)2D3 administration, serum osteocalcin values significantly increased (P < 0.001) from baseline in both children with IJO and controls, reaching peak values not significantly different in the two groups. Our results do not support the hypothesis that defective osteoblast function is the primary factor of bone demineralization in IJO.
引用
收藏
页码:20 / 23
页数:4
相关论文
共 20 条
[1]  
AUDRAN M, 1986, SEMIN NEPHROL, V6, P4
[2]  
Berglund G, 1960, CLIN ORTHOP RELAT R, V17, P259
[3]   SERUM OSTEOCALCIN CONCENTRATIONS IN CHILDREN WITH METABOLIC BONE-DISEASE [J].
COLE, DEC ;
CARPENTER, TO ;
GUNDBERG, CM .
JOURNAL OF PEDIATRICS, 1985, 106 (05) :770-776
[4]   1,25-DIHYDROXYVITAMIN-D STIMULATION TEST FOR OSTEOBLAST FUNCTION IN NORMAL AND OSTEOPOROTIC POSTMENOPAUSAL WOMEN [J].
DUDA, RJ ;
KUMAR, R ;
NELSON, KI ;
ZINSMEISTER, AR ;
MANN, KG ;
RIGGS, BL .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (04) :1249-1253
[5]  
EXNER GU, 1984, HELV PAEDIATR ACTA, V39, P517
[6]  
HUGHES A, 1986, HDB ENDOCRINE TESTS
[7]   JUVENILE OSTEOPOROSIS - BONE FINDINGS IN 7 PATIENTS [J].
JOWSEY, J ;
JOHNSON, KA .
JOURNAL OF PEDIATRICS, 1972, 81 (03) :511-+
[8]  
KOOH SW, 1973, CLIN ASPECTS BONE DI, P329
[9]   CALCITRIOL DEFICIENCY IN IDIOPATHIC JUVENILE OSTEOPOROSIS [J].
MARDER, HK ;
TSANG, RC ;
HUG, G ;
CRAWFORD, AC .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1982, 136 (10) :914-917
[10]   ORAL INTAKE OF PHOSPHORUS CAN DETERMINE THE SERUM CONCENTRATION OF 1,25-DIHYDROXYVITAMIN-D BY DETERMINING ITS PRODUCTION-RATE IN HUMANS [J].
PORTALE, AA ;
HALLORAN, BP ;
MURPHY, MM ;
MORRIS, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (01) :7-12